NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹41 Cr | ₹20 Cr | ₹50 Cr | ₹57 Cr | ₹833,528 Cr |
What is the latest Profit After Tax of NGL FINECHEM ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹41 Cr |
| Mar2024 | ₹20 Cr |
| Mar2023 | ₹50 Cr |
| Mar2022 | ₹57 Cr |
| Mar2021 | ₹833,528 Cr |
How is Profit After Tax of NGL FINECHEM Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹41 Cr | 101.59 | |
| Mar2024 | ₹20 Cr | -58.92 | |
| Mar2023 | ₹50 Cr | -12.03 | |
| Mar2022 | ₹57 Cr | -99.99 | |
| Mar2021 | ₹833,528 Cr | - | |
Compare Profit After Tax of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,438.7 Cr | 3.6% | 52.1% | 79.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹413,717.0 Cr | 0.6% | 7% | 1.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,830.0 Cr | 1.6% | 4.6% | 3.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹142,479.0 Cr | 3.1% | 5.9% | 39% | Stock Analytics | |
| CIPLA | ₹108,978.0 Cr | 1.5% | -2.1% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,905.0 Cr | 0.5% | 9.8% | 5.7% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 3.6% |
52.1% |
79.7% |
| SENSEX | -0.6% |
0.6% |
9.8% |
You may also like the below Video Courses